Search Results
10
Everything
Kane Biotech Secures IRB Approval to Launch Innovative DispersinB® Acne Trial
March 13, 2025 08:30 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, March 13, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) ("Kane Biotech" or "Kane") announces today that it has received approval from the Internal Review...